Nuestra Evidencia

Revisiones Cochrane donde han participado autores peruanos

  1. Salazar  CA, Basilio Flores  JE, Veramendi Espinoza  LE, Mejia Dolores  JW, Rey Rodriguez  DE, Loza Munárriz  C. Ranolazine for stable angina pectoris. Cochrane Database of Systematic Reviews 2017, Issue 2. Art. No.: CD011747. DOI: 10.1002/14651858.CD011747.pub2.
  2. Bravo Zuñiga  JI, Loza Munárriz  C, López‐Alcalde  J. Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in haemodialysis units. Cochrane Database of Systematic Reviews 2016, Issue 8. Art. No.: CD006420. DOI: 10.1002/14651858.CD006420.pub2.
  3. Henriquez‐Camacho  C, Gotuzzo  E, Echevarria  J, White Jr  AC, Terashima  A, Samalvides  F, Pérez‐Molina  JA, Plana  MN. Ivermectin versus albendazole or thiabendazole for   Strongyloides stercoralis infection. Cochrane Database of Systematic Reviews 2016, Issue 1. Art. No.: CD007745. DOI: 10.1002/14651858.CD007745.pub3.
  4. Garcia  P, Ruiz  W, Loza Munárriz  C. Warfarin initiation nomograms for venous thromboembolism. Cochrane Database of Systematic Reviews 2016, Issue 1. Art. No.: CD007699. DOI: 10.1002/14651858.CD007699.pub3.
  5. Coronado Daza  J, Martí‐Carvajal  AJ, Ariza García  A, Rodelo Ceballos  J, Yomayusa González  N, Páez‐Canro  C, Loza Munárriz  C, Urrútia  G. Early versus delayed erythropoietin for the anaemia of end‐stage kidney disease. Cochrane Database of Systematic Reviews 2015, Issue 12. Art. No.: CD011122. DOI: 10.1002/14651858.CD011122.pub2.
  6. Salazar  CA, del Aguila  D, Cordova  EG. Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non‐valvular atrial fibrillation. Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD009893. DOI: 10.1002/14651858.CD009893.pub2.
  7. Bernaola Aponte G, Bada Mancilla CA, Carreazo NY, Rojas Galarza RA. Probiotics for treating persistent diarrhoea in children.Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No.: CD007401. DOI: 10.1002/14651858.CD007401.pub3.
  8. Prutsky  G, Domecq  JP, Salazar  CA, Accinelli  R. Antifibrinolytic therapy to reduce haemoptysis from any cause. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD008711. DOI: 10.1002/14651858.CD008711.pub2.
  9. Salazar  CA, Malaga  G, Malasquez  G. Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement. Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No.: CD005981. DOI: 10.1002/14651858.CD005981.pub2.

    

Protocolos de Revisiones Cochrane con participación de autores peruanos

  1. Salazar  CA, Malaga  G, Malasquez  G, Bernardo  R. Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair. Cochrane Database of Systematic Reviews 2015, Issue 6. Art. No.: CD011762. DOI: 10.1002/14651858.CD011762.